These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22474880)

  • 21. Fracture risk associated with chronic use of bisphosphonates: evidence today.
    Charopoulos I; Orme S; Giannoudis PV
    Expert Opin Drug Saf; 2011 Jan; 10(1):67-76. PubMed ID: 21121870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
    Pazianas M
    JAMA Intern Med; 2013 Jan; 173(1):79-80. PubMed ID: 23318593
    [No Abstract]   [Full Text] [Related]  

  • 23. Transient migratory osteoporosis or insufficiency fracture?
    Davis KW
    J Clin Rheumatol; 2009 Apr; 15(3):153. PubMed ID: 19349800
    [No Abstract]   [Full Text] [Related]  

  • 24. Atypical fractures, a biased perspective.
    Aspenberg P
    Injury; 2016 Jan; 47 Suppl 1():S28-30. PubMed ID: 26768286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How soon after hip fracture surgery should a patient start bisphosphonates?
    Seton M
    Cleve Clin J Med; 2010 Nov; 77(11):751-5. PubMed ID: 21048049
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bisphosphonate treatment of osteoporosis and other skeletal diseases].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2011 Feb; 131(3):244-7. PubMed ID: 21304573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Atypical femoral fractures in bisphosphonate therapy].
    Ballaschk A; Kalaitzis N; Röpke M; Piatek S
    Unfallchirurg; 2015 Jan; 118(1):88-91. PubMed ID: 24352201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonate therapy for osteoporosis: the long and short of it.
    Compston JE; Bilezikian JP
    J Bone Miner Res; 2012 Feb; 27(2):240-2. PubMed ID: 22271395
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diphosphonate treatment of osteoporosis and risk of atypical femoral fractures].
    Schwarz P
    Ugeskr Laeger; 2012 Jan; 174(1-2):30. PubMed ID: 22233716
    [No Abstract]   [Full Text] [Related]  

  • 30. Atypical Femoral Fractures Can Happen Even With Short Duration Bisphosphonate Treatment.
    Kohli R; Siva C
    Conn Med; 2015 Aug; 79(7):419-22. PubMed ID: 26411180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonate use and atypical femoral fractures: getting down to brass tacks.
    Bauer DC
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5207-9. PubMed ID: 21131542
    [No Abstract]   [Full Text] [Related]  

  • 33. Going on a drug holiday?
    Bonnick SL
    J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
    [No Abstract]   [Full Text] [Related]  

  • 34. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M
    Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical femoral fracture.
    Khan AA; Kaiser S
    CMAJ; 2017 Apr; 189(14):E542. PubMed ID: 28396331
    [No Abstract]   [Full Text] [Related]  

  • 36. Collapsed subchondral fatigue fracture of the femoral head.
    Lee YK; Yoo JJ; Koo KH; Yoon KS; Min BW; Kim HJ
    Orthop Clin North Am; 2009 Apr; 40(2):259-65. PubMed ID: 19358911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zoledronic acid--once-yearly. Corticosteroid-induced osteoporosis: no benefit.
    Prescrire Int; 2010 Apr; 19(106):63. PubMed ID: 20568485
    [No Abstract]   [Full Text] [Related]  

  • 38. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB
    Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inflammation of the jaws during treatment with bisphosphonates].
    Bartl R
    Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
    [No Abstract]   [Full Text] [Related]  

  • 40. Vitamin D receptor genotypes and response to zoledronic acid therapy in thalassemia-induced osteoporosis.
    Otrock ZK; Mahfouz RA; Charafeddine KM; Rayes RF; Zahed LF; Taher AT
    Ann Hematol; 2008 Nov; 87(11):947-8. PubMed ID: 18443790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.